INVEGATRINZAHCP.COM: Keyword Density Checker

Total words: 3336 | 2-word phrases: 869 | 3-word phrases: 973 | 4-word phrases: 1005

PAGE INFO

Title	Try to keep the title under 60 characters (67 characters) Official HCP Website \| INVEGA TRINZA® (paliperidone palmitate) HCP
Description	Try to keep the meta description between 50 - 160 characters (156 characters) Learn about INVEGA TRINZA®, an long-acting treatment that is administered 4 times a year. See full prescribing & safety info, including boxed warnings.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (59 characters) Sorry, you need to enable JavaScript to visit this website.

#	Keyword	Frequency	Density
1	janssen pharmaceuticals inc	4	0.41%
2	for at least	3	0.31%
3	palmitate 3month formulation	3	0.31%
4	at least 4	3	0.31%
5	of paliperidone palmitate	3	0.31%
6	the united states	2	0.21%
7	et al efficacy	2	0.21%
8	portrayal actor portrayal	2	0.21%
9	actor portrayal actor	2	0.21%
10	our privacy policy	2	0.21%
11	this site is	2	0.21%
12	after treatment with	2	0.21%
13	gopal s et	2	0.21%
14	s et al	2	0.21%
15	adequately treated with	2	0.21%
16	al efficacy and	2	0.21%
17	clinically stable schizophrenia	2	0.21%
18	longterm maintenance study	2	0.21%
19	sustenna® for at	2	0.21%
20	medical information center	2	0.21%
21	schizophrenia a randomized	2	0.21%
22	remission and goal	2	0.21%
23	symptomatic remission and	2	0.21%
24	3month formulation for	2	0.21%
25	paliperidone palmitate 3month	2	0.21%
26	with clinically stable	2	0.21%
27	in patients with	2	0.21%
28	3 months of	2	0.21%
29	least 4 months	2	0.21%
30	patients with schizophrenia	2	0.21%

#	Keyword	Frequency	Density
1	for at least 4	3	0.30%
2	paliperidone palmitate 3month formulation	2	0.20%
3	gopal s et al	2	0.20%
4	s et al efficacy	2	0.20%
5	et al efficacy and	2	0.20%
6	accessed april 29 2022	2	0.20%
7	with clinically stable schizophrenia	2	0.20%
8	palmitate 3month formulation for	2	0.20%
9	symptomatic remission and goal	2	0.20%
10	actor portrayal actor portrayal	2	0.20%
11	sustenna® for at least	2	0.20%
12	at least 4 months	2	0.20%
13	paliperidone palmitate vs placebo	1	0.10%
14	relapse prevention of schizophrenia	1	0.10%
15	j liu y gopal	1	0.10%
16	liu y gopal s	1	0.10%
17	y gopal s et	1	0.10%
18	of schizophrenia a randomized	1	0.10%
19	prevention of schizophrenia a	1	0.10%
20	efficacy and safety of	1	0.10%
21	al efficacy and safety	1	0.10%
22	of paliperidone palmitate vs	1	0.10%
23	the 3month formulation of	1	0.10%
24	3month formulation of paliperidone	1	0.10%
25	3 berwaerts j liu	1	0.10%
26	formulation of paliperidone palmitate	1	0.10%
27	palmitate vs placebo for	1	0.10%
28	berwaerts j liu y	1	0.10%
29	titusville nj janssen pharmaceuticals	1	0.10%
30	2021 3 berwaerts j	1	0.10%
31	for providers and organizations	1	0.10%
32	outside of the symphony	1	0.10%
33	of the symphony health	1	0.10%
34	the symphony health network10	1	0.10%
35	references 1 national council for	1	0.10%
36	council for mental wellbeing	1	0.10%
37	for mental wellbeing guide	1	0.10%
38	mental wellbeing guide to	1	0.10%
39	longacting medications for providers	1	0.10%
40	medications for providers and	1	0.10%

#	URL	Whois	Check
1	https://www.invegahafyerahcp.com/	Whois	invegahafyerahcp.com
2	http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+TRINZA-pi.pdf	Whois	janssenlabels.com
3	https://www.invegatrinza.com	Whois	invegatrinza.com
4	https://www.janssenconnectlocator.com	Whois	janssenconnectlocator.com
5	https://www.invegasustennahcp.com	Whois	invegasustennahcp.com
6	https://www.invegatrinza.com	Whois	invegatrinza.com
7	https://www.thenationalcouncil.org/resources/guide-to-long-acting-medications/	Whois	thenationalcouncil.org
8	https://symphonyhealth.com/what-we-do	Whois	symphonyhealth.com
9	http://www.janssenpharmaceuticalsinc.com/	Whois	janssenpharmaceuticalsinc.com
10	https://www.janssenmd.com	Whois	janssenmd.com
11	http://www.janssenmd.com	Whois	janssenmd.com
12	https://www.janssen.com/us/privacy-request	Whois	janssen.com